Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeSales of Property, Plant and EquipmentSales of Property, Plant and EquipmentShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kezar Life Sciences (KZR) Cash from Investing Activities (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Cash from Investing Activities for 5 consecutive years, with $51.6 million as the latest value for Q4 2025.

  • For Q4 2025, Cash from Investing Activities rose 117.37% year-over-year to $51.6 million; the TTM value through Dec 2025 reached $92.5 million, up 14.96%, while the annual FY2025 figure was $92.5 million, 14.96% up from the prior year.
  • Cash from Investing Activities hit $51.6 million in Q4 2025 for Kezar Life Sciences, up from $15.7 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $51.6 million in Q4 2025 and bottomed at -$82.5 million in Q4 2021.
  • Average Cash from Investing Activities over 5 years is $6.5 million, with a median of $14.7 million recorded in 2025.
  • Year-over-year, Cash from Investing Activities tumbled 8565.65% in 2022 and then soared 774.37% in 2023.
  • Kezar Life Sciences' Cash from Investing Activities stood at -$82.5 million in 2021, then skyrocketed by 89.5% to -$8.7 million in 2022, then skyrocketed by 421.88% to $27.9 million in 2023, then decreased by 14.83% to $23.7 million in 2024, then surged by 117.37% to $51.6 million in 2025.
  • According to Business Quant data, Cash from Investing Activities over the past three periods came in at $51.6 million, $15.7 million, and $11.4 million for Q4 2025, Q3 2025, and Q2 2025 respectively.